These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 32875686)

  • 41. Efficacy and tolerability of pharmacotherapies for attention-deficit hyperactivity disorder in adults.
    Santosh PJ; Sattar S; Canagaratnam M
    CNS Drugs; 2011 Sep; 25(9):737-63. PubMed ID: 21870887
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Risk of serious cardiovascular problems with medications for attention-deficit hyperactivity disorder.
    Martinez-Raga J; Knecht C; Szerman N; Martinez MI
    CNS Drugs; 2013 Jan; 27(1):15-30. PubMed ID: 23160939
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Efficacy, safety and variability in pharmacotherapy for adults with attention deficit hyperactivity disorder: a meta-analysis and meta-regression in over 9000 patients.
    Cunill R; Castells X; Tobias A; Capellà D
    Psychopharmacology (Berl); 2016 Jan; 233(2):187-97. PubMed ID: 26446868
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Attention-deficit/hyperactivity disorder symptoms and suicide ideation and attempts: Findings from the Adult Psychiatric Morbidity Survey 2007.
    Stickley A; Koyanagi A; Ruchkin V; Kamio Y
    J Affect Disord; 2016 Jan; 189():321-8. PubMed ID: 26469299
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Estimated prevalence and associated risk factors of attention deficit hyperactivity disorder (ADHD) among medical college students in a Chinese population.
    Shen Y; Chan BSM; Liu J; Meng F; Yang T; He Y; Lu J; Luo X; Zhang XY
    J Affect Disord; 2018 Dec; 241():291-296. PubMed ID: 30142587
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Meta-Analysis: Reduced Risk of Anxiety with Psychostimulant Treatment in Children with Attention-Deficit/Hyperactivity Disorder.
    Coughlin CG; Cohen SC; Mulqueen JM; Ferracioli-Oda E; Stuckelman ZD; Bloch MH
    J Child Adolesc Psychopharmacol; 2015 Oct; 25(8):611-7. PubMed ID: 26402485
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Acetaminophen use during pregnancy and the risk of attention deficit hyperactivity disorder: A causal association or bias?
    Masarwa R; Platt RW; Filion KB
    Paediatr Perinat Epidemiol; 2020 May; 34(3):309-317. PubMed ID: 31916282
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Risk of Irritability With Psychostimulant Treatment in Children With ADHD: A Meta-Analysis.
    Stuckelman ZD; Mulqueen JM; Ferracioli-Oda E; Cohen SC; Coughlin CG; Leckman JF; Bloch MH
    J Clin Psychiatry; 2017 Jun; 78(6):e648-e655. PubMed ID: 28682529
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Use of medication by young people with attention-deficit/hyperactivity disorder.
    Sawyer MG; Rey JM; Graetz BW; Clark JJ; Baghurst PA
    Med J Aust; 2002 Jul; 177(1):21-5. PubMed ID: 12088474
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Medication for Attention-Deficit/Hyperactivity Disorder and Risk for Depression: A Nationwide Longitudinal Cohort Study.
    Chang Z; D'Onofrio BM; Quinn PD; Lichtenstein P; Larsson H
    Biol Psychiatry; 2016 Dec; 80(12):916-922. PubMed ID: 27086545
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Suicidality and its relationships with individual, family, peer, and psychopathology factors among adolescents with attention-deficit/hyperactivity disorder.
    Chou WJ; Liu TL; Hu HF; Yen CF
    Res Dev Disabil; 2016; 53-54():86-94. PubMed ID: 26867785
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Impact of Central Nervous System Stimulant Medication Use on Growth in Pediatric Populations with Attention-Deficit/Hyperactivity Disorder: A Review.
    Troksa K; Kovacich N; Moro M; Chavez B
    Pharmacotherapy; 2019 Jun; 39(6):665-676. PubMed ID: 30368860
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Meta-analysis of functional magnetic resonance imaging studies of inhibition and attention in attention-deficit/hyperactivity disorder: exploring task-specific, stimulant medication, and age effects.
    Hart H; Radua J; Nakao T; Mataix-Cols D; Rubia K
    JAMA Psychiatry; 2013 Feb; 70(2):185-98. PubMed ID: 23247506
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Attention-Deficit/Hyperactivity Disorder Medication and Unintentional Injuries in Children and Adolescents.
    Ghirardi L; Larsson H; Chang Z; Chen Q; Quinn PD; Hur K; Gibbons RD; D'Onofrio BM
    J Am Acad Child Adolesc Psychiatry; 2020 Aug; 59(8):944-951. PubMed ID: 31302218
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of stimulant medication on neuropsychological functioning in young adults with attention-deficit/hyperactivity disorder.
    Biederman J; Seidman LJ; Petty CR; Fried R; Doyle AE; Cohen DR; Kenealy DC; Faraone SV
    J Clin Psychiatry; 2008 Jul; 69(7):1150-6. PubMed ID: 18517288
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antidepressant use during pregnancy and risk of autism spectrum disorder and attention deficit hyperactivity disorder: systematic review of observational studies and methodological considerations.
    Morales DR; Slattery J; Evans S; Kurz X
    BMC Med; 2018 Jan; 16(1):6. PubMed ID: 29332605
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Immediate-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults.
    Epstein T; Patsopoulos NA; Weiser M
    Cochrane Database Syst Rev; 2014 Sep; (9):CD005041. PubMed ID: 25230710
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A cohort study of the risk of seizures in a pediatric population treated with atomoxetine or stimulant medications.
    McAfee AT; Landon J; Jones M; Bangs ME; Acharya N; Hornbuckle K; Wong J
    Pharmacoepidemiol Drug Saf; 2013 Apr; 22(4):386-93. PubMed ID: 23280590
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Long-term stimulant medication treatment of attention-deficit/hyperactivity disorder: results from a population-based study.
    Barbaresi WJ; Katusic SK; Colligan RC; Weaver AL; Leibson CL; Jacobsen SJ
    J Dev Behav Pediatr; 2014 Sep; 35(7):448-57. PubMed ID: 25180895
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pharmacologic treatment of attention deficit hyperactivity disorder in adults: A systematic review and network meta-analysis.
    Elliott J; Johnston A; Husereau D; Kelly SE; Eagles C; Charach A; Hsieh SC; Bai Z; Hossain A; Skidmore B; Tsakonas E; Chojecki D; Mamdani M; Wells GA
    PLoS One; 2020; 15(10):e0240584. PubMed ID: 33085721
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.